Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Subjects With Mild-to-moderate Asthma and in Healthy Volunteers

NCT04082754 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT04082754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04082754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Subjects With Mild-to-moderate Asthma and in Healthy Volunteers
Lead sponsor
CSL Behring
Phase
Phase 1
Overall status
Completed
Start date
November 28, 2019
Completion date
November 14, 2023
Enrollment
78 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

asthma